| Literature DB >> 34941765 |
Mieko Takasaka1,2, Shinsuke Kobayashi3, Yuki Usui3, Hisao Haniu1, Shuji Tsuruoka4, Kaoru Aoki5, Naoto Saito1.
Abstract
Considerable progress has been made in various fields of applied research on the use of carbon nanotubes (CNTs). Because CNTs are fibrous nanomaterials, biosafety of CNTs has been discussed. The biokinetic data of CNTs, such as using the radioisotope of carbon and surface labeling of CNTs, have been reported. However, the use of radioisotopes requires a special facility. In addition, there are problems in the surface labeling of CNTs, including changes in surface properties and labels eliminating over time. In order to solve these problems and properly evaluate the biokinetics of CNTs, the authors synthesize peapods with platinum (Pt) encapsulated within the hollow region of Double-Walled CNTs (DWCNTs) and develop a new system to evaluate biokinetics using widely available imaging equipment. In the cell assay, no significant difference is observed with and without Pt in CNTs. In animal studies, radiography of the lungs of rats that inhaled Pt-peapods show the detectability of Pt inside the CNTs. This new method using Pt-peapods enables image evaluation with a standard radiographic imaging device without changing the surface property of the CNTs and is effective for biokinetics evaluation of CNTs.Entities:
Keywords: biodistribution; biokinetics; carbon nanotube; peapod
Year: 2021 PMID: 34941765 PMCID: PMC8705935 DOI: 10.3390/toxics9120331
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Figure 1Transmission Electron Microscopy (TEM) image and X-ray fluorescence (XRF) spectrum of platinum(Pt)-peapods: (a) In the TEM image, the hollow structure of carbon nanotubes (CNTs) was filled with platinum (II) chloride (PtCl2) molecules (red arrow). Scale bar: 1 nm. (b) From the XRF spectrum, the Pt content was about 2 wt%, which was approximately the same as the theoretical saturation.
Figure 2Heated CNTs and Pt-peapods showed similar cell responsiveness in cell assay for lung-related cells, human malignant pleural mesothelioma cells (MESO-1) and human adenocarcinoma cells (A549). (a,b) Cytotoxicity test. (a) MESO-1 cells. (b) A549 cells. Mean ± S.E. (n = 6). (c,d) Cellular uptake assay. (c) MESO-1 cells. (d) A549 cells. Mean ± S.E. (n = 4). * p < 0.05, ** p < 0.01.
Figure 3Cytokine secretion assay for lung-related cells MESO-1 and A549: (a–c) MESO-1 cells. (d,e) A549 cells. Mean ± S.E. (n = 4). * p < 0.05, ** p < 0.01 (Compared to control), # p < 0.05, ## p < 0.01 (Compared to each concentration).
Figure 4Histological image of the removed lung and X-ray image: (a) Light microscopy (left) and polarization microscopy (right) at 1 week after intratracheal administration of Pt-peapods. Pt-peapods were deposited from the main bronchus to the peripheral bronchi. Hematoxylin-Eosin Stain. Scale bar: 300 μm. (b) Diagrams for 3D configuration (left) and high absorber detection (right) of 3D micro X-ray CT scanning. A large number of highly absorptive substances in the lung (red dot: minimum of approximately 100 µm3) were confirmed from around the tracheal bifurcation to the pulmonary lobe. (c) Red point indicates the point of measurement in the 3D micro X-ray CT image of the right lobe. (d) The number of particles in each pulmonary lobe after 1 week of intratracheal administration. (e) An image (left) of a tissue section of the lung at 1 week after administration of Pt-peapods taken by 3D X-ray microscopy, and an enlarged image in the yellow frame. Pulmonary alveolus was visualized and Pt-peapods as small as approximately 1 µm could be confirmed.